Financials surging as investors countdown to second quarter bank earnings next week, expecting major growth. The traders break down what the results could mean for these names and whether banks will see major gains. Then, shares of Kymera Therapeutics soaring as its Eczema drug trial timeline moves faster than expected. The firm’s founder, president and CEO Nello Mainolfi talks trial data and where the company is heading next. Plus, SpaceX stock plummeting despite bull calls on the Street, the media market under pressure, and Coke hitting all-time highs back to its century-old IPO.<br><br>Fast Money Disclaimer<br><br>Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26

CNBC's "Fast Money"

Hey Fidelity, what's it cost to invest with the Fidelity app? Start with as little as $1 with no account fees or trade commissions on U.S. stocks and ETFs. Hmm, that's music to my ears. I can only talk. Investing involves risk, including risk of loss. Zero account fees apply to retail brokerage accounts only. Zero dollar commission does not apply to customers designated by Fidelity as a professional equity trader. A limited number of ETFs are subject to a service fee of $100. See details at Fidelity.com slash commissions. Fidelity Brokerage Services, LLC, member NYSE SIPC.

Ever notice how life's best stories don't happen in your living room? They happen on the open road, out on the water, or parked under the stars. At Progressive, they get that you want to focus on the experience, not worry about the what-ifs. That's why they offer quality insurance designed for your ride, whether that's a boat, RV, or motorcycle. Adventure with confidence. Visit Progressive.com and see how easy it is to protect your favorite way to get away.

Progressive Casualty Insurance Company and affiliates. Not available in D.C. Prices vary based on how you buy. Live from the NASDAQ MarketSite in the heart of New York City's Times Square, this is Fast Money. Here's what's on tap tonight. Big banks about to kick off Q2 earnings season next week. Investment banks leading the way over the last three months. What will the reports mean for these names? And for gains in the second half of the year.

Plus, the next big test for chip stocks, a sky-high price target for SpaceX, Coca-Cola shares get caffeinated, and CNBC investigates concerns that censors from a blacklisted Chinese company could be hacked or used to send sensitive data to the Chinese government.

U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26

Read the full transcript

The candid version is on a podcast,
not the earnings call.

U.S. Banking Boom…And Record Stock Run for Kymera Therapeutics 7/7/26

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.